ARS Pharmaceuticals (SPRY) Short-term Investments (2022 - 2026)
ARS Pharmaceuticals' Short-term Investments came in at $135.68 million for Q2 2026, down 28.1% from $188.59 million a year earlier and down 23.2% from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Short-term Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, ARS Pharmaceuticals' Short-term Investments was $203.67 million, down 22.6% from FY2024.
- Short-term Investments carries a three-year compound annual growth rate of 47.2% (FY2022 to FY2025).
- Going back by year, Short-term Investments was $263.21 million in FY2024 (+67.2%), $157.39 million in FY2023 (+146.4%) and $63.86 million in FY2022.
- The Q2 2026 figure represents the lowest quarterly Short-term Investments since Q2 2023.
- Year-over-year, Short-term Investments has declined for three consecutive quarters, with growth averaging 8.2% over the last eight quarters.
- The fastest year-over-year change in Short-term Investments over five years came in Q1 2023 (growth of 789.8%), and the weakest in Q2 2026 (a decline of 28.1%).
- Business Quant data shows SPRY's Short-term Investments at $176.65 million (Q1 2026), $203.67 million (Q4 2025) and $228.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | ARS Pharmaceuticals | 428.58 Mn | 284.78 Mn | 20.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 135.68 Mn |
| Mar 31, 2026 | 176.65 Mn |
| Dec 31, 2025 | 203.67 Mn |
| Sep 30, 2025 | 228.65 Mn |
| Jun 30, 2025 | 188.59 Mn |
| Mar 31, 2025 | 235.86 Mn |
| Dec 31, 2024 | 263.21 Mn |
| Sep 30, 2024 | 164.97 Mn |
| Jun 30, 2024 | 182.12 Mn |
| Mar 31, 2024 | 167.63 Mn |
| Dec 31, 2023 | 157.39 Mn |
| Sep 30, 2023 | 181.37 Mn |
| Jun 30, 2023 | 133.19 Mn |
| Mar 31, 2023 | 176.69 Mn |
| Dec 31, 2022 | 63.86 Mn |
| Sep 30, 2022 | 63.40 Mn |
| Jun 30, 2022 | 39.29 Mn |
| Mar 31, 2022 | 19.86 Mn |
API Access
ARS Pharmaceuticals Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();